title: Erratum to: single-agent bevacizumab is an effective treatment in recurrent glioblastoma.
authors.affiliation: Department of Medical Oncology, Faculty of Medicine, Trakya University, 22030, Edirne, Turkey, ilhanhbo@hotmail.com.
authors.forename: Ilhan
authors.initials: I
authors.lastname: Hacibekiroglu
authors.forename: Hilmi
authors.initials: H
authors.lastname: Kodaz
authors.forename: Bulent
authors.initials: B
authors.lastname: Erdogan
authors.forename: Esma
authors.initials: E
authors.lastname: Turkmen
authors.forename: Melike
authors.initials: M
authors.lastname: Ozcelik
authors.forename: Asim
authors.initials: A
authors.lastname: Esenkaya
authors.forename: Haci Mehmet
authors.initials: HM
authors.lastname: Saygi
authors.forename: Sernaz
authors.initials: S
authors.lastname: Uzunoglu
authors.forename: Irfan
authors.initials: I
authors.lastname: Cicin